Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Towards a neuroimaging biomarker for amyotrophic lateral sclerosis.

Turner MR, Grosskreutz J, Kassubek J, Abrahams S, Agosta F, Benatar M, Filippi M, Goldstein LH, van den Heuvel M, Kalra S, Lulé D, Mohammadi B; first Neuroimaging Symosium in ALS (NISALS).

Lancet Neurol. 2011 May;10(5):400-3. doi: 10.1016/S1474-4422(11)70049-7. No abstract available.

PMID:
21511189
2.

Progress towards a neuroimaging biomarker for amyotrophic lateral sclerosis.

Filippi M, Agosta F, Grosskreutz J, Benatar M, Kassubek J, Verstraete E, Turner MR; Neuroimaging Society in ALS (NiSALS).

Lancet Neurol. 2015 Aug;14(8):786-8. doi: 10.1016/S1474-4422(15)00134-9. No abstract available.

PMID:
26194923
3.

The present and the future of neuroimaging in amyotrophic lateral sclerosis.

Agosta F, Chiò A, Cosottini M, De Stefano N, Falini A, Mascalchi M, Rocca MA, Silani V, Tedeschi G, Filippi M.

AJNR Am J Neuroradiol. 2010 Nov;31(10):1769-77. doi: 10.3174/ajnr.A2043. Epub 2010 Apr 1. Review.

4.

25 years of neuroimaging in amyotrophic lateral sclerosis.

Foerster BR, Welsh RC, Feldman EL.

Nat Rev Neurol. 2013 Sep;9(9):513-24. doi: 10.1038/nrneurol.2013.153. Epub 2013 Aug 6. Review.

5.

MRI as a frontrunner in the search for amyotrophic lateral sclerosis biomarkers?

Turner MR.

Biomark Med. 2011 Feb;5(1):79-81. doi: 10.2217/bmm.10.120. No abstract available.

6.

Biomarkers in amyotrophic lateral sclerosis.

Turner MR, Kiernan MC, Leigh PN, Talbot K.

Lancet Neurol. 2009 Jan;8(1):94-109. doi: 10.1016/S1474-4422(08)70293-X. Review.

PMID:
19081518
8.

Neuroimaging in amyotrophic lateral sclerosis.

Turner MR, Agosta F, Bede P, Govind V, Lulé D, Verstraete E.

Biomark Med. 2012 Jun;6(3):319-37. doi: 10.2217/bmm.12.26. Review.

9.

Evaluation and management of amyotrophic lateral sclerosis.

Valadi N.

Prim Care. 2015 Jun;42(2):177-87. doi: 10.1016/j.pop.2015.01.009. Epub 2015 Apr 7. Review.

PMID:
25979579
10.

Management of amyotrophic lateral sclerosis.

Bali T, Miller TM.

Mo Med. 2013 Sep-Oct;110(5):417-21. Review.

PMID:
24279194
11.

Bright tongue sign: a diagnostic marker for amyotrophic lateral sclerosis.

Souza PV, Pinto WB, Oliveira AS.

Arq Neuropsiquiatr. 2014 Jul;72(7):572. No abstract available.

13.

Neuroimaging in amyotrophic lateral sclerosis.

Kalra S, Arnold D.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Dec;4(4):243-8. Review.

PMID:
14753658
14.

Neuroimaging in amyotrophic lateral sclerosis.

Wang S, Melhem ER, Poptani H, Woo JH.

Neurotherapeutics. 2011 Jan;8(1):63-71. doi: 10.1007/s13311-010-0011-3. Review.

15.

Magnetic resonance imaging of the brain: are findings suggestive of amyotrophic lateral sclerosis of any diagnostic utility?

Eid J, Tamler MS.

PM R. 2011 Jun;3(6):594-5. doi: 10.1016/j.pmrj.2010.12.012. No abstract available.

PMID:
21665173
16.

Magnetic resonance imaging in amyotrophic lateral sclerosis.

Goodin DS, Rowley HA, Olney RK.

Ann Neurol. 1988 Apr;23(4):418-20.

PMID:
3382182
17.

Signal loss in the motor cortex on magnetic resonance images in amyotrophic lateral sclerosis.

Ishikawa K, Nagura H, Yokota T, Yamanouchi H.

Ann Neurol. 1993 Feb;33(2):218-22.

PMID:
8434885
18.
19.

[Diagnosis of amyotrophic lateral sclerosis: advances in magnetic resonance imaging].

Alvarez-Uría Tejero MJ, Sáiz Ayala A, Fernández Rey C, Santamarta Liébana ME, Costilla García S.

Radiologia. 2011 Mar-Apr;53(2):146-55. doi: 10.1016/j.rx.2010.10.004. Epub 2011 Apr 1. Review. Spanish.

20.

[Amyotrophic lateral sclerosis].

Veldink JH, Weikamp J, Schelhaas HJ, van den Berg LH.

Ned Tijdschr Tandheelkd. 2010 Jul-Aug;117(7-8):380-2. Review. Dutch.

PMID:
20726497

Supplemental Content

Support Center